The products of ecological textile have represented nowadays the new trend ofglobal consumption and production of textile while become an important means for some countries toutilize 'green barrier' as a limit...The products of ecological textile have represented nowadays the new trend ofglobal consumption and production of textile while become an important means for some countries toutilize 'green barrier' as a limitation of import of textile products. Following the entrance ofChina into the WTO, the position of 'green barrier' becomes significantly important in the trade oftextile products. As China is a big country of textile production, speeding up the research onstandards for products of ecological textile, countering the latest situation appearing ininternational trade of textile, to take as quickly as possible responsive measures is a very urgentproblem in port, to enhancing the ability of international market competition and to promoting thestable development of foreign oriented economy.展开更多
The modern history of management systems is almost the same as the history ofmodem management science. Implicit management systems have been in existence for many 100s ofyears. ISO has paid attention to the issue of t...The modern history of management systems is almost the same as the history ofmodem management science. Implicit management systems have been in existence for many 100s ofyears. ISO has paid attention to the issue of the integrated management systems since the ISO 9000family standards for quality management systems (QMS) and ISO 14000 series standards for environmentmanagement system (EMS) were published. ISO/TAG (Technical Advisory Group) 12 was formed by theISO/TM (Technical Management Board) in early 1997 with the mandate to achieve greater compatibilitybetween the relevant ISO/TC 176 and ISO/TC 207 standards in the field of management systems,auditing, terms and definitions. The report was submitted to TMB by TAG 12 in 1999.展开更多
AIM： To investigate results availability from clinical studies enrolling Russian subjects and Russian clinical research policy.METHODS： We analyzed Russian legislation and ethi-cal regulations about drug and devices...AIM： To investigate results availability from clinical studies enrolling Russian subjects and Russian clinical research policy.METHODS： We analyzed Russian legislation and ethi-cal regulations about drug and devices approval, clini-cal research registration and the results availability. In August 2012, we searched International Clinical Trials Registry Platform and clinicaltrials.gov to fnd all regis-tered studies that had an investigational site in the ter-ritory of the Russian Federation. To fnd publication sta-tus, we searched the PubMed and Scirus bibliographical databases with trial registration number to fnd journal publications of the registered studies.RESULTS： We identifed 2062 registered research pro-tocols comprising 2017 international and 45 protocols sponsored by the Russian funding agencies. The num-ber of the studies enrolling Russian subjects increased dramatically from three studies in 2002 to 252 studies in 2012. Most studies （92%） were funded exclusively by industry, were interventions （94.6%）, examined drugs （87%） and enrolled exclusively adults （86%） of both genders （89%）. Only 383 （19%） of multinational stud-ies and two （4.4%） of exclusively Russian studies werepublished. Posting of patient outcomes was available for 16% of the trials that recruited trial participants in the Russian territory including one study funded exclu-sively by Russian sponsors. Investigators terminated 99 studies of 38111 participants and did not provide the results in clinicaltrials.gov or in published manuscripts. Federal laws require clinical study registration and con-fict of interest disclosure. However, routine monitoring of compliance to clinical research policy is not available.CONCLUSION： Russian legislation does not guarantee the availability of clinical research results. Russian leg-islation should mandate transparent evidence- based market approval of the drugs and devices.展开更多
A strategic agreement was signed between Chengdu Bureau of Quality and Technological Supervision and Sichuan University on＂jointly building South Asia Standardization（Chengdu）Research Center＂on November 15,2017.Th...A strategic agreement was signed between Chengdu Bureau of Quality and Technological Supervision and Sichuan University on＂jointly building South Asia Standardization（Chengdu）Research Center＂on November 15,2017.The research center is designed as a national top-level think tank of integrated research on policies,rules and standards at both national and regional levels in South Asia.展开更多
Automotive Standardization Research Institute ’is, specialized in the standardization and technical regulation research for automobiles and motorcycles. Its main activities include: Nationwide Auto Standardization Te...Automotive Standardization Research Institute ’is, specialized in the standardization and technical regulation research for automobiles and motorcycles. Its main activities include: Nationwide Auto Standardization Technology Comprehensive展开更多
Innovative development extends the vitality of ethnomedicines. Developing ethnomedicines is not only beneficial to the public but also to the related industry and transforms economic growth, driving local social and e...Innovative development extends the vitality of ethnomedicines. Developing ethnomedicines is not only beneficial to the public but also to the related industry and transforms economic growth, driving local social and economic development further. Its economic benefit can be used to optimize and promote the hardware and software of the platform, as well as support the sustainable development of ethnomedicines. Apart from research and discussion on the innovative development of ethnomedicines on the basis of theory and regulations, this series of articles also summarizes cases that are conducive to the overall understanding of the necessity and feasibility of the innovative development. In terms of industrial development, large enterprises and products, such as Yunnan Baiyao, Guizhou Miao ethnomedicines, Cheezheng Tibetan Medicine, products developed from Dengzhanhua （Erigeron breviscapus）, the Gold series of Yi ethnomedicines, and products developed from Sanqi （Panax notoginseng）, in China are introduced and summarized, focusing on resource superiority, sustainable innovation, standard research and development, and production, as well as intellectual property protection.展开更多
One of the primary purposes of the innovative development of ethnomedicines is to use their excellent safety and significant efficacy to serve a broader population. To achieve this purpose, modern scientific and techn...One of the primary purposes of the innovative development of ethnomedicines is to use their excellent safety and significant efficacy to serve a broader population. To achieve this purpose, modern scientific and technological means should be referenced, and relevant national laws and regulations as well as technical guides should be strictly followed to develop standards and to perform systemic research in producing ethnomedicines. Finally, ethnomedicines, which are applied to a limited extent in ethnic areas, can be transformed into safe, effective, and quality-controllable medical products to relieve the pain of more patients. The innovative development path of ethnomedicines includes the following three primary stages： resource study, standardized development research, and industrialization of the achievements and efforts for internationalization. The implementation of this path is always guaranteed by the research and development platform and the talent team. This article is based on the accumulation of long-term practice and is combined with the relevant disciplines, laws and regulations, and technical guidance from the research and development of ethnomedicines. The intention is to perform an in-depth analysis and explanation of the major research thinking, methods, contents, and technical paths involved in all stages of the innovative development path of ethnomedicines to provide useful references for the development of proper ethnomedicine use.展开更多
文摘The products of ecological textile have represented nowadays the new trend ofglobal consumption and production of textile while become an important means for some countries toutilize 'green barrier' as a limitation of import of textile products. Following the entrance ofChina into the WTO, the position of 'green barrier' becomes significantly important in the trade oftextile products. As China is a big country of textile production, speeding up the research onstandards for products of ecological textile, countering the latest situation appearing ininternational trade of textile, to take as quickly as possible responsive measures is a very urgentproblem in port, to enhancing the ability of international market competition and to promoting thestable development of foreign oriented economy.
文摘The modern history of management systems is almost the same as the history ofmodem management science. Implicit management systems have been in existence for many 100s ofyears. ISO has paid attention to the issue of the integrated management systems since the ISO 9000family standards for quality management systems (QMS) and ISO 14000 series standards for environmentmanagement system (EMS) were published. ISO/TAG (Technical Advisory Group) 12 was formed by theISO/TM (Technical Management Board) in early 1997 with the mandate to achieve greater compatibilitybetween the relevant ISO/TC 176 and ISO/TC 207 standards in the field of management systems,auditing, terms and definitions. The report was submitted to TMB by TAG 12 in 1999.
文摘AIM： To investigate results availability from clinical studies enrolling Russian subjects and Russian clinical research policy.METHODS： We analyzed Russian legislation and ethi-cal regulations about drug and devices approval, clini-cal research registration and the results availability. In August 2012, we searched International Clinical Trials Registry Platform and clinicaltrials.gov to fnd all regis-tered studies that had an investigational site in the ter-ritory of the Russian Federation. To fnd publication sta-tus, we searched the PubMed and Scirus bibliographical databases with trial registration number to fnd journal publications of the registered studies.RESULTS： We identifed 2062 registered research pro-tocols comprising 2017 international and 45 protocols sponsored by the Russian funding agencies. The num-ber of the studies enrolling Russian subjects increased dramatically from three studies in 2002 to 252 studies in 2012. Most studies （92%） were funded exclusively by industry, were interventions （94.6%）, examined drugs （87%） and enrolled exclusively adults （86%） of both genders （89%）. Only 383 （19%） of multinational stud-ies and two （4.4%） of exclusively Russian studies werepublished. Posting of patient outcomes was available for 16% of the trials that recruited trial participants in the Russian territory including one study funded exclu-sively by Russian sponsors. Investigators terminated 99 studies of 38111 participants and did not provide the results in clinicaltrials.gov or in published manuscripts. Federal laws require clinical study registration and con-fict of interest disclosure. However, routine monitoring of compliance to clinical research policy is not available.CONCLUSION： Russian legislation does not guarantee the availability of clinical research results. Russian leg-islation should mandate transparent evidence- based market approval of the drugs and devices.
文摘A strategic agreement was signed between Chengdu Bureau of Quality and Technological Supervision and Sichuan University on＂jointly building South Asia Standardization（Chengdu）Research Center＂on November 15,2017.The research center is designed as a national top-level think tank of integrated research on policies,rules and standards at both national and regional levels in South Asia.
文摘Automotive Standardization Research Institute ’is, specialized in the standardization and technical regulation research for automobiles and motorcycles. Its main activities include: Nationwide Auto Standardization Technology Comprehensive
文摘Innovative development extends the vitality of ethnomedicines. Developing ethnomedicines is not only beneficial to the public but also to the related industry and transforms economic growth, driving local social and economic development further. Its economic benefit can be used to optimize and promote the hardware and software of the platform, as well as support the sustainable development of ethnomedicines. Apart from research and discussion on the innovative development of ethnomedicines on the basis of theory and regulations, this series of articles also summarizes cases that are conducive to the overall understanding of the necessity and feasibility of the innovative development. In terms of industrial development, large enterprises and products, such as Yunnan Baiyao, Guizhou Miao ethnomedicines, Cheezheng Tibetan Medicine, products developed from Dengzhanhua （Erigeron breviscapus）, the Gold series of Yi ethnomedicines, and products developed from Sanqi （Panax notoginseng）, in China are introduced and summarized, focusing on resource superiority, sustainable innovation, standard research and development, and production, as well as intellectual property protection.
文摘One of the primary purposes of the innovative development of ethnomedicines is to use their excellent safety and significant efficacy to serve a broader population. To achieve this purpose, modern scientific and technological means should be referenced, and relevant national laws and regulations as well as technical guides should be strictly followed to develop standards and to perform systemic research in producing ethnomedicines. Finally, ethnomedicines, which are applied to a limited extent in ethnic areas, can be transformed into safe, effective, and quality-controllable medical products to relieve the pain of more patients. The innovative development path of ethnomedicines includes the following three primary stages： resource study, standardized development research, and industrialization of the achievements and efforts for internationalization. The implementation of this path is always guaranteed by the research and development platform and the talent team. This article is based on the accumulation of long-term practice and is combined with the relevant disciplines, laws and regulations, and technical guidance from the research and development of ethnomedicines. The intention is to perform an in-depth analysis and explanation of the major research thinking, methods, contents, and technical paths involved in all stages of the innovative development path of ethnomedicines to provide useful references for the development of proper ethnomedicine use.
